Researcher
Patrik Verstreken
- Disciplines (Flanders Institute for Biotechnology):Analysis of next-generation sequence data, Cell death, Behavioural neuroscience
- Disciplines (KU Leuven):Neurological and neuromuscular diseases
- See also: Patrik Verstreken (Flanders Institute for Biotechnology)
Affiliations
- Research Group Molecular Neurobiology (VIB-KU Leuven) (Division)
Responsible
From1 Jan 2017 → Today - Laboratory of Neuronal Communication (VIB-KU Leuven) (Lab)
Responsible
From1 Jan 2008 → Today - Laboratory of Neuronal Communication (VIB-KU Leuven) (Lab)
Member
From1 Jan 2017 → Today - VIB-KU Leuven Center for Brain & Disease Research (Research Center)
Responsible
From1 Jan 2017 → Today - Verstreken Lab (Research group)
Responsible
From1 Jan 2017 → Today - Department of Human Genetics (Department)
Member
From1 Apr 2009 → 31 Dec 2016
Projects
1 - 10 of 54
- The Role of Parkinsonism genes in synaptic autophagyFrom1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
- Tau-dependent synaptic remodeling in health and diseaseFrom1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
- Translational Markers for Precision Medicine in Modifying Parkinson's DiseaseFrom1 Feb 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Investigating cell type specific defects in protein quality control across the genetic landscape of Parkinson’s diseaseFrom1 Oct 2022 → TodayFunding: FWO junior postdoctoral fellowship
- When size matters: a platform to study molecular interactions and multimerisationFrom1 May 2022 → TodayFunding: FWO Medium Size Research Infrastructure
- Dissecting the genetic interactions controlling α-Synuclein accumulation in Parkinson’s DiseaseFrom15 Mar 2022 → TodayFunding: FWO fellowships
- Analyzing the regulation of synaptic vesicle mobility by pre-synaptic liquid phase-separation in health and diseaseFrom7 Mar 2022 → TodayFunding: FWO fellowships
- Therapeutic targeting of pathogenic presynaptic Tau in human neurons in a chimeric Alzheimer’s Disease mouse modelFrom24 Jan 2022 → TodayFunding: FWO Strategic Basic Research Grant
- Investigating cell type specific defects in protein quality control across the genetic landscape of Parkinson’s disease.From1 Oct 2021 → 30 Sep 2022Funding: BOF - postdoctoral mandates
- Resilience and vulnerability in the cellular phase of Alzheimer’s disease.From1 Oct 2021 → TodayFunding: BOF - Methusalem
Publications
31 - 40 of 146
- A Single-Cell Transcriptome Atlas of the Aging Drosophila Brain(2018)
Authors: Kristofer Davie, Jasper Janssens, Uli Pech, Valerie Christiaens, Carmen Bravo González-Blas, Katina Spanier, Thomas Moerman, Sarah Geurs, Thierry Voet, Jeroen Lammertyn, et al.
Pages: 982 - 998 - ER Lipid Defects in Neuropeptidergic Neurons Impair Sleep Patterns in Parkinson's Disease(2018)
Authors: Patrik Verstreken
Pages: 1155 - + - Deficiency of parkin and PINK1 impairs age-dependent mitophagy in Drosophila(2018)
Authors: Tom Cornelissen, Patrik Verstreken, Wim Vandenberghe
- In vivo single-molecule imaging of syntaxin1A reveals polyphosphoinositide-and activity- dependent trapping in presynaptic nanoclusters (vol 7, 13660, 2016)(2018)
Authors: Adekunle T Bademosi, Elsa Lauwers, Pranesh Padmanabhan, Lorenzo Odierna, Ye Jin Chai, Andreas Papadopulos, Geoffrey J Goodhill, Patrik Verstreken, Bruno van Swinderen, Frederic A Meunier
- p13 protects against Parkinson's disease(2018)
Authors: Jorge De Sousa Valadas, Patrik Verstreken
- Synaptogyrin-3 Mediates Presynaptic Dysfunction Induced by Tau(2018)
Authors: Joseph McInnes, Laura Bounti, Yu-Chun Wang, Nuno Apóstolo, Bart De Strooper, Joris de Wit, Lujia Zhou, Patrik Verstreken
Pages: 823 - 835 - Reprogramming neurodegeneration in the big data era(2018)
Authors: Patrik Verstreken
Pages: 167 - 173 - Trapping of Syntaxin1a in Presynaptic Nanoclusters by a Clinically Relevant General Anesthetic(2018)
Authors: Adekunle Bademosi, Elsa Lauwers, Patrik Verstreken
Pages: 427 - 440 - In Vivo Single-Molecule Tracking at the Drosophila Presynaptic Motor Nerve Terminal(2018)
Authors: Adekunle Bademosi, Elsa Lauwers, Patrik Verstreken
- α-Synuclein and Tau: Mitochondrial Kill Switches(2018)
Authors: Uli Pech, Patrik Verstreken
Pages: 3 - 4
Patents
1 - 10 of 10
- Screening method for synaptogyrin-3 inhibitors (Inventor)
- Targeting synaptogyrin-3 in tauopathy treatment (Inventor)
- Targeting synaptogyrin-3 in tauopathy treatment (Inventor)
- Means and methods for treatment of early-onset parkinson's disease (Inventor)
- Means and methods for treatment of early-onset parkinson's disease (Inventor)
- Compounds for treatment of intractable epilepsy and doors syndrome (Inventor)
- Targeting synaptogyrin-3 in tauopathy treatment (Inventor)
- Compounds for treatment of intractable epilepsy and doors syndrome (Inventor)
- Restoring phosphorylation of a novel pink1 substrate to treat parkinson's disease (Inventor)
- Restoring phosphorylation of a novel pink1 substrate to treat parkinson's disease (Inventor)